Guizhou Yibai Pharmaceutical Co. Ltd. Class ASSE: 600594

"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on Resolutions of the 2nd Meeting of the 9th Board of Directors

Aug 21, 2026 · Issued by Guizhou Yibai Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Announcement on Resolutions of the 2nd Meeting of the 9th Board of Directors

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Guizhou Yibai Pharmaceutical Co. Ltd. Class A

"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on the Selection of Products in the Second Round of Follow-Up Centralized Procurement by the National Alliance for Chinese Patent Medicine ProcurementAug 4
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on the Receipt of the "Administrative Penalty Notice" from Guizhou Provincial Drug AdministrationAug 1
"Guizhou Yibai Pharmaceutical Co., Ltd."Semi-annual Performance Forecast for 2026Jul 15
"Guizhou Yibai Pharmaceutical Co., Ltd."Announcement on Inclusion of the Company's Pharmaceutical Products in the "National Essential Medicines List (2026 Edition)"Jul 11

All Guizhou Yibai Pharmaceutical Co. Ltd. Class A news releases